NYSE:THC - Tenet Healthcare Stock Price, Price Target & More

$23.48 -0.99 (-4.05 %)
(As of 04/26/2018 11:19 AM ET)
Previous Close$24.47
Today's Range$23.12 - $23.98
52-Week Range$12.25 - $25.24
Volume870,559 shs
Average Volume2.30 million shs
Market Capitalization$2.42 billion
P/E Ratio30.21
Dividend YieldN/A
Beta0.8

About Tenet Healthcare (NYSE:THC)

Tenet Healthcare logoTenet Healthcare Corporation operates as a diversified healthcare services company. It operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The company's general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. It also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; tertiary care services, including cardiothoracic surgery, neonatal intensive care, and neurosciences; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, the company operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals, as well as Aspen's hospitals and clinics; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. Further, it offers accounts receivable and health information management, and revenue integrity and patient financial services; patient communications and engagement services; and clinical integration, financial risk management, and population health management services. As of December 31, 2017, the company operated 76 hospitals, 20 surgical hospitals, and approximately 470 outpatient centers, as well as 247 ambulatory surgery, 34 urgent care, and 23 imaging centers in the United States; and 9 private hospitals and clinics in the United Kingdom. The company was founded in 1967 and is headquartered in Dallas, Texas.

Receive THC News and Ratings via Email

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNYSE:THC
CUSIP88033G40
Phone469-893-2200

Debt

Debt-to-Equity Ratio27.44%
Current Ratio1.29%
Quick Ratio1.22%

Price-To-Earnings

Trailing P/E Ratio30.21
Forward P/E Ratio24.98
P/E Growth2.02

Sales & Book Value

Annual Sales$19.18 billion
Price / Sales0.12
Cash Flow$9.7025 per share
Price / Cash2.42
Book Value$5.34 per share
Price / Book4.40

Profitability

EPS (Most Recent Fiscal Year)$0.81
Net Income$-704,000,000.00
Net Margins-3.67%
Return on Equity9.69%
Return on Assets0.34%

Miscellaneous

Employees126,000
Outstanding Shares101,110,000

How to Become a New Pot Stock Millionaire

Tenet Healthcare (NYSE:THC) Frequently Asked Questions

What is Tenet Healthcare's stock symbol?

Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare (NYSE:THC) released its quarterly earnings data on Monday, February, 26th. The company reported $1.40 EPS for the quarter, beating the Zacks' consensus estimate of $1.25 by $0.15. The business earned $4.98 billion during the quarter, compared to analysts' expectations of $4.85 billion. Tenet Healthcare had a negative net margin of 3.67% and a positive return on equity of 9.69%. The firm's quarterly revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.06 EPS. View Tenet Healthcare's Earnings History.

When is Tenet Healthcare's next earnings date?

Tenet Healthcare is scheduled to release their next quarterly earnings announcement on Monday, April, 30th 2018. View Earnings Estimates for Tenet Healthcare.

What guidance has Tenet Healthcare issued on next quarter's earnings?

Tenet Healthcare updated its FY18 earnings guidance on Monday, February, 26th. The company provided earnings per share guidance of $0.73-$1.07 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.78. The company issued revenue guidance of $17.9-$18.3 billion, compared to the consensus revenue estimate of $18.26 billion.Tenet Healthcare also updated its Q1 guidance to ($0.10)-$0.05 EPS.

What price target have analysts set for THC?

16 Wall Street analysts have issued 1-year target prices for Tenet Healthcare's shares. Their forecasts range from $15.00 to $30.00. On average, they anticipate Tenet Healthcare's stock price to reach $22.2667 in the next year. View Analyst Ratings for Tenet Healthcare.

Are investors shorting Tenet Healthcare?

Tenet Healthcare saw a drop in short interest in the month of March. As of March 15th, there was short interest totalling 21,496,017 shares, a drop of 9.9% from the February 28th total of 23,848,997 shares. Based on an average trading volume of 2,705,248 shares, the short-interest ratio is presently 7.9 days. Currently, 21.7% of the shares of the company are short sold.

Who are some of Tenet Healthcare's key competitors?

Who are Tenet Healthcare's key executives?

Tenet Healthcare's management team includes the folowing people:
  • Mr. Ronald A. Rittenmeyer, Exec. Chairman & CEO (Age 71)
  • Mr. Daniel J. Cancelmi, Chief Financial Officer (Age 55)
  • Ms. Audrey T. Andrews, Sr. VP & Gen. Counsel (Age 51)
  • Mr. Keith B. Pitts, Vice Chairman (Age 60)
  • Mr. Jason Eric Evans, Pres of Hospital Operations (Age 41)

Has Tenet Healthcare been receiving favorable news coverage?

Media coverage about THC stock has trended somewhat positive on Thursday, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Tenet Healthcare earned a media sentiment score of 0.11 on Accern's scale. They also assigned headlines about the company an impact score of 47.48 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Tenet Healthcare's major shareholders?

Tenet Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional investors include GLENVIEW CAPITAL MANAGEMENT, LLC (17.74%) and GLENVIEW CAPITAL MANAGEMENT, LLC (17.77%). Company insiders that own Tenet Healthcare stock include Ashish Dave, George Fredrick Smitherman, Peter M Wilver and Ronald A Rittenmeyer. View Institutional Ownership Trends for Tenet Healthcare.

How do I buy shares of Tenet Healthcare?

Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tenet Healthcare's stock price today?

One share of THC stock can currently be purchased for approximately $23.52.

How big of a company is Tenet Healthcare?

Tenet Healthcare has a market capitalization of $2.42 billion and generates $19.18 billion in revenue each year. The company earns $-704,000,000.00 in net income (profit) each year or $0.81 on an earnings per share basis. Tenet Healthcare employs 126,000 workers across the globe.

How can I contact Tenet Healthcare?

Tenet Healthcare's mailing address is 1445 ROSS AVENUE SUITE 1400, DALLAS TX, 75202. The company can be reached via phone at 469-893-2200 or via email at [email protected]


MarketBeat Community Rating for Tenet Healthcare (THC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  401 (Vote Outperform)
Underperform Votes:  522 (Vote Underperform)
Total Votes:  923
MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare and other stocks. Vote "Outperform" if you believe THC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe THC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tenet Healthcare (NYSE:THC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
16 Wall Street analysts have issued ratings and price targets for Tenet Healthcare in the last 12 months. Their average twelve-month price target is $22.2667, suggesting that the stock has a possible downside of 5.17%. The high price target for THC is $30.00 and the low price target for THC is $15.00. There are currently 2 sell ratings, 7 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.312.312.292.40
Ratings Breakdown: 2 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
6 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
9 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $22.2667$21.4667$18.3077$20.5714
Price Target Upside: 5.17% downside10.82% downside14.49% upside56.44% upside

Tenet Healthcare (NYSE:THC) Consensus Price Target History

Price Target History for Tenet Healthcare (NYSE:THC)

Tenet Healthcare (NYSE:THC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/17/2018SunTrust BanksReiterated RatingHold$27.00LowView Rating Details
3/22/2018MizuhoReiterated RatingBuy$29.00HighView Rating Details
3/5/2018JPMorgan ChaseBoost Price TargetUnderweight -> Underweight$15.00 -> $18.00LowView Rating Details
3/1/2018Piper JaffrayReiterated RatingHold$21.00HighView Rating Details
3/1/2018CitigroupBoost Price TargetBuy -> Buy$19.00 -> $27.00LowView Rating Details
2/28/2018Morgan StanleyBoost Price TargetUnderweight -> Underweight$15.00 -> $16.00MediumView Rating Details
2/28/2018Wells FargoBoost Price TargetMarket Perform -> Market Perform$20.00 -> $22.00HighView Rating Details
2/28/2018Raymond JamesUpgradeMarket Perform -> Outperform$30.00HighView Rating Details
2/27/2018Jefferies GroupSet Price TargetBuy$23.00LowView Rating Details
1/3/2018Goldman SachsInitiated CoverageNeutral -> Neutral$15.00HighView Rating Details
12/20/2017Leerink SwannReiterated RatingBuy$27.00LowView Rating Details
11/21/2017William BlairReiterated RatingMarket PerformN/AView Rating Details
11/13/2017Royal Bank of CanadaLower Price TargetSector Perform$19.00 -> $17.00N/AView Rating Details
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$15.00N/AView Rating Details
9/28/2017Robert W. BairdReiterated RatingBuy$23.00HighView Rating Details
9/1/2017Deutsche BankReiterated RatingBuy$24.00LowView Rating Details
1/11/2017UBSReiterated RatingBuy$26.00 -> $24.00N/AView Rating Details
11/9/2016Bank of AmericaDowngradeBuy -> Neutral$32.00 -> $25.00N/AView Rating Details
10/25/2016Wolfe ResearchInitiated CoverageMarket PerformN/AView Rating Details
8/19/2016BarclaysReiterated RatingBuy$39.00N/AView Rating Details
6/13/2016Ladenburg ThalmannUpgradeNot Rated -> UnderperformN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Tenet Healthcare (NYSE:THC) Earnings History and Estimates Chart

Earnings by Quarter for Tenet Healthcare (NYSE:THC)

Tenet Healthcare (NYSE:THC) Earnings Estimates

2018 EPS Consensus Estimate: $0.93
2019 EPS Consensus Estimate: $1.74
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184($0.03)$0.03$0.01
Q2 20184$0.10$0.29$0.18
Q3 20184($0.03)$0.28$0.14
Q4 20184$0.29$0.93$0.59
Q1 20192($0.03)($0.01)($0.02)
Q2 20192$0.24$0.31$0.28
Q3 20192$0.24$0.36$0.30
Q4 20192$1.06$1.30$1.18

Tenet Healthcare (NYSE THC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/30/2018$0.09N/AView Earnings Details
2/26/2018Q4 2017$1.25$1.40$4.8518 billion$4.9780 billionViewN/AView Earnings Details
11/6/2017Q3 2017($0.40)($0.17)$4.9445 billion$4.5860 billionViewN/AView Earnings Details
10/27/2017Q3 2017($0.38)($0.17)$4.7264 billion$4.5860 billionViewN/AView Earnings Details
8/7/2017Q2 2017($0.17)($0.17)$4.9012 billion$14.8020 billionViewListenView Earnings Details
5/1/2017Q1 2017($0.5230)($0.27)$4.8441 billion$4.8130 billionViewListenView Earnings Details
2/27/2017Q416$0.22$0.06$4.95 billion$4.86 billionViewN/AView Earnings Details
10/31/2016Q316$0.17$0.16$2.28 billion$4.85 billionViewN/AView Earnings Details
8/1/2016Q216$0.52$0.38$4.82 billion$4.87 billionViewN/AView Earnings Details
5/2/2016Q116$0.34$0.45$4.79 billion$5.0440 billionViewN/AView Earnings Details
2/22/2016Q415$0.34$0.35$4.82 billion$5.2060 billionViewListenView Earnings Details
11/2/2015Q315$0.27$0.29$4.67 billion$4.6920 billionViewN/AView Earnings Details
8/3/2015Q215$0.44$0.75$4.37 billion$4.4920 billionViewN/AView Earnings Details
5/4/2015Q115$0.31$0.67$4.33 billion$4.43 billionViewN/AView Earnings Details
2/23/2015Q414$1.18$1.03$4.34 billion$4.8240 billionViewN/AView Earnings Details
11/3/2014Q314$0.10$0.09$4.02 billion$4.18 billionViewListenView Earnings Details
8/4/2014Q214$0.01($0.27)$3.94 billion$4.04 billionViewN/AView Earnings Details
5/5/2014Q114($0.14)($0.12)$3.91 billion$3.93 billionViewListenView Earnings Details
2/24/2014Q413$0.37$0.49$3.87 billion$3.89 billionViewN/AView Earnings Details
11/5/2013Q313$0.45$0.45$2.38 billion$2.6180 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.75($0.49)$2.46 billion$2.42 billionViewN/AView Earnings Details
4/30/2013Q1 2013$0.31$0.33$2.46 billion$2.5940 billionViewListenView Earnings Details
2/26/2013Q4 2012$0.68$0.45$2.34 billion$2.33 billionViewListenView Earnings Details
11/7/2012Q312$0.32$0.34$2.4157 billion$2.4270 billionViewN/AView Earnings Details
8/7/2012$0.05$0.10ViewN/AView Earnings Details
5/8/2012$0.10$0.13ViewN/AView Earnings Details
2/28/2012$0.14$0.10ViewN/AView Earnings Details
11/1/2011$0.04ViewN/AView Earnings Details
8/2/2011$0.08$0.09ViewN/AView Earnings Details
5/3/2011$0.14$0.17ViewN/AView Earnings Details
2/25/2011$0.08$0.14ViewN/AView Earnings Details
11/2/2010Q3 2010$0.20($0.04)ViewN/AView Earnings Details
8/3/2010Q2 2010$0.24$0.28ViewN/AView Earnings Details
5/4/2010Q1 2010$0.28$0.65ViewN/AView Earnings Details
2/23/2010Q4 2009$0.04$0.30ViewN/AView Earnings Details
11/3/2009Q3 2009($0.08)$0.12ViewN/AView Earnings Details
8/4/2009Q2 2009$0.18ViewN/AView Earnings Details
5/5/2009Q1 2009$0.12$0.40ViewN/AView Earnings Details
2/24/2009Q4 2008($0.12)($0.08)ViewN/AView Earnings Details
11/3/2008Q3 2008($0.12)($0.27)ViewN/AView Earnings Details
8/5/2008Q2 2008($0.04)($0.03)ViewN/AView Earnings Details
5/6/2008Q1 2008$0.04$0.17ViewN/AView Earnings Details
2/26/2008Q4 2007($0.12)($0.42)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Tenet Healthcare (NYSE:THC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Tenet Healthcare (NYSE THC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%
Insider Trading History for Tenet Healthcare (NYSE:THC)
Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Tenet Healthcare (NYSE THC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/9/2018Ashish DaveDirectorSell75,000$1.40$105,000.00
2/5/2018George Fredrick SmithermanDirectorSell39,000$0.39$15,210.00
1/30/2018George Fredrick SmithermanDirectorSell14,300$2.02$28,886.00
1/25/2018George Fredrick SmithermanDirectorBuy125,000$38.50$4,812,500.00
1/15/2018George Fredrick SmithermanDirectorSell1,300$38.50$50,050.00
11/11/2016Ronald A RittenmeyerDirectorBuy15,000$14.35$215,250.0023,783View SEC Filing  
11/9/2016Peter M WilverDirectorBuy5,000$15.19$75,950.005,000View SEC Filing  
11/13/2015Glenview Capital Management, LMajor ShareholderBuy900,000$32.56$29,304,000.00View SEC Filing  
10/22/2015Glenview Capital Management, LMajor ShareholderBuy500,000$29.71$14,855,000.00View SEC Filing  
9/30/2015Glenview Capital Management, LMajor ShareholderBuy500,000$36.30$18,150,000.00View SEC Filing  
8/25/2015Glenview Capital Management, LMajor ShareholderBuy500,000$48.39$24,195,000.00View SEC Filing  
7/14/2015Trevor FetterCEOSell96,477$60.40$5,827,210.80View SEC Filing  
7/13/2015Trevor FetterCEOSell88,004$60.08$5,287,280.32View SEC Filing  
7/6/2015Trevor FetterCEOSell83,443$60.02$5,008,248.86View SEC Filing  
6/25/2015Glenview Capital Management, LMajor ShareholderBuy979,482$54.93$53,802,946.26View SEC Filing  
6/25/2015Trevor FetterCEOSell47,711$55.02$2,625,059.22View SEC Filing  
6/4/2015R. Scott RamseyInsiderSell5,650$51.64$291,766.00View SEC Filing  
8/18/2014Trevor FetterCEOSell33,642$60.01$2,018,856.42View SEC Filing  
8/14/2014Britt T ReynoldsInsiderSell8,028$58.49$469,557.72View SEC Filing  
8/8/2014Audrey T AndrewsSVPSell2,208$56.31$124,332.48View SEC Filing  
8/8/2014Daniel J CancelmiCFOSell12,291$56.88$699,112.08View SEC Filing  
8/8/2014R. Scott RamseyInsiderSell2,083$56.27$117,210.41View SEC Filing  
8/7/2014Trevor FetterCEOSell138,665$56.12$7,781,879.80View SEC Filing  
7/25/2014Trevor FetterCEOSell41,000$51.34$2,104,940.00View SEC Filing  
6/9/2014Britt T ReynoldsInsiderSell35,000$49.82$1,743,700.00View SEC Filing  
5/22/2014Trevor FetterCEOSell35,394$47.52$1,681,922.88963,790View SEC Filing  
5/15/2014Richard PettingillDirectorSell10,000$45.22$452,200.0016,464View SEC Filing  
5/12/2014Edward KangasChairmanSell12,000$44.29$531,480.0024,198View SEC Filing  
4/25/2014Trevor FetterCEOSell57,735$45.00$2,598,075.00999,184View SEC Filing  
3/24/2014Audrey AndrewsSVPSell13,624$40.17$547,276.08View SEC Filing  
12/23/2013Glenview Capital Management, Lmajor shareholderBuy248,910$39.79$9,904,128.90View SEC Filing  
12/20/2013Glenview Capital Management, Lmajor shareholderBuy644,582$39.95$25,751,050.90View SEC Filing  
12/18/2013Glenview Capital Management, Lmajor shareholderBuy1,000,000$40.12$40,120,000.00View SEC Filing  
11/15/2013Keith PittsChairmanBuy6,250$43.13$269,562.5025,000View SEC Filing  
11/14/2013Keith PittsChairmanBuy6,250$43.14$269,625.0018,750View SEC Filing  
11/8/2013Keith PittsChairmanBuy7,500$41.85$313,875.0012,500View SEC Filing  
11/7/2013Keith PittsChairmanBuy5,000$41.97$209,850.005,000View SEC Filing  
10/3/2013John Ellis BushDirectorSell16,582$45.10$747,848.20View SEC Filing  
9/19/2013John Ellis BushDirectorSell8,291$42.90$355,683.9036,913View SEC Filing  
5/14/2013Glenview Capital Management, LMajor ShareholderSell4,000,000$47.75$191,000,000.00View SEC Filing  
3/5/2013Edward A KangasChairmanSell7,000$39.88$279,160.00View SEC Filing  
3/4/2013Trevor FetterCEOSell138,255$39.39$5,445,864.45View SEC Filing  
10/19/2012Glenview Capital Management LlMajor ShareholderBuy200,000$23.53$4,706,000.00View SEC Filing  
10/16/2012Glenview Capital Management LlMajor ShareholderBuy433,383$23.98$10,392,524.34View SEC Filing  
9/17/2012Glenview Capital Management LlMajor ShareholderBuy750,000$5.75$4,312,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tenet Healthcare (NYSE THC) News Headlines

Source:
DateHeadline
Encoda Hires Industry Veteran to Direct Its Rapidly Growing Revenue Cycle Management Services DivisionEncoda Hires Industry Veteran to Direct Its Rapidly Growing Revenue Cycle Management Services Division
finance.yahoo.com - April 26 at 8:09 AM
Traders Purchase Large Volume of Call Options on Tenet Healthcare (THC)Traders Purchase Large Volume of Call Options on Tenet Healthcare (THC)
www.americanbankingnews.com - April 25 at 8:38 AM
Q1 2018 EPS Estimates for Tenet Healthcare (THC) Cut by AnalystQ1 2018 EPS Estimates for Tenet Healthcare (THC) Cut by Analyst
www.americanbankingnews.com - April 25 at 6:54 AM
Tenet Healthcare (THC) to Release Earnings on MondayTenet Healthcare (THC) to Release Earnings on Monday
www.americanbankingnews.com - April 23 at 7:14 AM
Tenet beats class action stemming from kickback probeTenet beats class action stemming from kickback probe
www.reuters.com - April 19 at 8:08 AM
Zacks: Brokerages Anticipate Tenet Healthcare (THC) Will Announce Quarterly Sales of $4.59 BillionZacks: Brokerages Anticipate Tenet Healthcare (THC) Will Announce Quarterly Sales of $4.59 Billion
www.americanbankingnews.com - April 18 at 2:26 AM
Tenet Healthcare (THC) Stock Rating Reaffirmed by SunTrust BanksTenet Healthcare (THC) Stock Rating Reaffirmed by SunTrust Banks
www.americanbankingnews.com - April 17 at 9:19 AM
Tenet Healthcare (THC) Expected to Post Earnings of -$0.02 Per ShareTenet Healthcare (THC) Expected to Post Earnings of -$0.02 Per Share
www.americanbankingnews.com - April 16 at 5:12 PM
Banner Health agreed to pay $18M to settle false claims act allegationsBanner Health agreed to pay $18M to settle false claims act allegations
www.bizjournals.com - April 13 at 8:10 AM
Tenet Healthcare (THC) Receives "Buy" Rating from Jefferies GroupTenet Healthcare (THC) Receives "Buy" Rating from Jefferies Group
www.americanbankingnews.com - April 12 at 7:57 PM
Tenet Healthcare (THC) Receives "Outperform" Rating from Robert W. BairdTenet Healthcare (THC) Receives "Outperform" Rating from Robert W. Baird
www.americanbankingnews.com - April 11 at 5:35 PM
Tenet Healthcare Corp (THC) Receives Consensus Rating of "Hold" from BrokeragesTenet Healthcare Corp (THC) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 11 at 9:43 AM
Deutsche Bank Reaffirms "Buy" Rating for Tenet Healthcare (THC)Deutsche Bank Reaffirms "Buy" Rating for Tenet Healthcare (THC)
www.americanbankingnews.com - April 10 at 8:23 PM
Tenet Healthcare (THC) Given a $15.00 Price Target at SunTrust BanksTenet Healthcare (THC) Given a $15.00 Price Target at SunTrust Banks
www.americanbankingnews.com - April 7 at 12:31 PM
Tenet Healthcare (THC) Stock Rating Lowered by ValuEngineTenet Healthcare (THC) Stock Rating Lowered by ValuEngine
www.americanbankingnews.com - April 2 at 11:26 PM
Tenet Healthcare Corp (THC) Short Interest Down 9.9% in MarchTenet Healthcare Corp (THC) Short Interest Down 9.9% in March
www.americanbankingnews.com - April 2 at 2:52 AM
Tenet Healthcare Corp (THC) Expected to Announce Quarterly Sales of $4.59 BillionTenet Healthcare Corp (THC) Expected to Announce Quarterly Sales of $4.59 Billion
www.americanbankingnews.com - April 1 at 2:16 AM
 Analysts Expect Tenet Healthcare Corp (THC) Will Announce Earnings of -$0.02 Per Share Analysts Expect Tenet Healthcare Corp (THC) Will Announce Earnings of -$0.02 Per Share
www.americanbankingnews.com - March 30 at 9:16 PM
Inovalon Announces New Post Acute Care Services Agreement with Tenet HealthcareInovalon Announces New Post Acute Care Services Agreement with Tenet Healthcare
finance.yahoo.com - March 28 at 8:19 AM
Tenet Healthcare Sees Unusually High Options Volume (THC)Tenet Healthcare Sees Unusually High Options Volume (THC)
www.americanbankingnews.com - March 28 at 7:22 AM
Tenet Healthcare Reaches Deal With Glenview Capital Management - Quick FactsTenet Healthcare Reaches Deal With Glenview Capital Management - Quick Facts
www.nasdaq.com - March 27 at 8:16 AM
Tenet Healthcare (THC) Enters Pact with Glenview CapitalTenet Healthcare (THC) Enters Pact with Glenview Capital
www.streetinsider.com - March 26 at 5:27 PM
Tenet Healthcare up 1.5% premarket after Glenview withdraws bid to change certain bylawsTenet Healthcare up 1.5% premarket after Glenview withdraws bid to change certain bylaws
seekingalpha.com - March 26 at 5:27 PM
Tenet Reaches Agreement with GlenviewTenet Reaches Agreement with Glenview
finance.yahoo.com - March 26 at 8:12 AM
Tenet Healthcare (THC) Given "Buy" Rating at MizuhoTenet Healthcare (THC) Given "Buy" Rating at Mizuho
www.americanbankingnews.com - March 22 at 9:20 PM
How Amedisys’s Business Segments Have PerformedHow Amedisys’s Business Segments Have Performed
finance.yahoo.com - March 19 at 8:12 AM
Tenet Healthcare Corp (THC) Receives Consensus Recommendation of "Hold" from AnalystsTenet Healthcare Corp (THC) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 17 at 10:09 AM
TheStreet Upgrades Tenet Healthcare (THC) to "C"TheStreet Upgrades Tenet Healthcare (THC) to "C"
www.americanbankingnews.com - March 15 at 1:00 PM
$4.59 Billion in Sales Expected for Tenet Healthcare Corp (THC) This Quarter$4.59 Billion in Sales Expected for Tenet Healthcare Corp (THC) This Quarter
www.americanbankingnews.com - March 15 at 3:44 AM
Tenet Healthcare Corp (THC) Director Ashish Dave Sells 75,000 SharesTenet Healthcare Corp (THC) Director Ashish Dave Sells 75,000 Shares
www.americanbankingnews.com - March 14 at 10:41 PM
"Fast Money" final trades: IBM, JPM and more"Fast Money" final trades: IBM, JPM and more
finance.yahoo.com - March 14 at 7:17 PM
Tenet Healthcare Corp (THC) Expected to Post Earnings of -$0.02 Per ShareTenet Healthcare Corp (THC) Expected to Post Earnings of -$0.02 Per Share
www.americanbankingnews.com - March 13 at 5:18 PM
Tenet Healthcare (THC) Rating Increased to Hold at Zacks Investment ResearchTenet Healthcare (THC) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - March 13 at 3:41 PM
Exploring Tenet Healthcare’s Financial PerformanceExploring Tenet Healthcare’s Financial Performance
finance.yahoo.com - March 13 at 8:13 AM
Understanding Tenet Healthcare’s Business StrategyUnderstanding Tenet Healthcare’s Business Strategy
finance.yahoo.com - March 12 at 6:47 PM
Tenet Announces New Presentation Time for the Barclays Global Healthcare ConferenceTenet Announces New Presentation Time for the Barclays Global Healthcare Conference
finance.yahoo.com - March 12 at 6:47 PM
Analyzing the Performances of Tenet’s Business SegmentsAnalyzing the Performances of Tenet’s Business Segments
finance.yahoo.com - March 12 at 6:47 PM
Tenet Healthcare Reaches Analyst Target Price - NasdaqTenet Healthcare Reaches Analyst Target Price - Nasdaq
www.nasdaq.com - March 8 at 8:12 AM
ValuEngine Upgrades Tenet Healthcare (THC) to BuyValuEngine Upgrades Tenet Healthcare (THC) to Buy
www.americanbankingnews.com - March 8 at 12:28 AM
Tenet Healthcare Corp (THC) to Post Q1 2018 Earnings of $0.03 Per Share, William Blair ForecastsTenet Healthcare Corp (THC) to Post Q1 2018 Earnings of $0.03 Per Share, William Blair Forecasts
www.americanbankingnews.com - March 7 at 7:32 AM
Tenet Healthcare (THC) PT Maintained at $30 at Baird on Enhanced Governance Savings; Shares Still MispricedTenet Healthcare (THC) PT Maintained at $30 at Baird on Enhanced Governance Savings; 'Shares Still Mispriced'
www.streetinsider.com - March 6 at 5:46 PM
See what the IHS Markit Score report has to say about Tenet Healthcare Corp.See what the IHS Markit Score report has to say about Tenet Healthcare Corp.
finance.yahoo.com - March 6 at 5:46 PM
Tenet Healthcare Corp to Post Q3 2018 Earnings of $0.10 Per Share, William Blair Forecasts (THC)Tenet Healthcare Corp to Post Q3 2018 Earnings of $0.10 Per Share, William Blair Forecasts (THC)
www.americanbankingnews.com - March 6 at 8:56 AM
Tenet Healthcare Sells MacNeal Hospital to Streamline TradeTenet Healthcare Sells MacNeal Hospital to Streamline Trade
www.zacks.com - March 5 at 5:56 PM
BRIEF-Tenet Healthcare ‍Board Modifying Bylaws To Reduce Threshold Required To Request Special MeetingBRIEF-Tenet Healthcare ‍Board Modifying Bylaws To Reduce Threshold Required To Request Special Meeting
www.reuters.com - March 5 at 5:56 PM
JPMorgan Chase & Co. Reiterates "Sell" Rating for Tenet Healthcare (THC)JPMorgan Chase & Co. Reiterates "Sell" Rating for Tenet Healthcare (THC)
www.americanbankingnews.com - March 5 at 1:36 PM
Leerink Swann Weighs in on Tenet Healthcare Corps Q1 2018 Earnings (THC)Leerink Swann Weighs in on Tenet Healthcare Corp's Q1 2018 Earnings (THC)
www.americanbankingnews.com - March 5 at 1:12 AM
Tenet Healthcare (THC) Raised to Buy at ValuEngineTenet Healthcare (THC) Raised to Buy at ValuEngine
www.americanbankingnews.com - March 4 at 3:04 PM
Spark Investment Management LLC Takes $1.64 Million Position in Tenet Healthcare Corp (THC)Spark Investment Management LLC Takes $1.64 Million Position in Tenet Healthcare Corp (THC)
www.americanbankingnews.com - March 3 at 12:36 PM
Leerink Swann Analysts Lift Earnings Estimates for Tenet Healthcare Corp (THC)Leerink Swann Analysts Lift Earnings Estimates for Tenet Healthcare Corp (THC)
www.americanbankingnews.com - March 2 at 10:14 AM

SEC Filings

Tenet Healthcare (NYSE:THC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tenet Healthcare (NYSE:THC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tenet Healthcare (NYSE THC) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.